Atsuhiko Sato1, Shunsuke Kawamoto2, Mika Watanabe3, Yusuke Suzuki1, Goro Takahashi1, Naoki Masaki1, Kiichiro Kumagai1, Yoshifumi Saijo4, Koichi Tabayashi1, Yoshikatsu Saiki1. 1. Division of Cardiovascular Surgery, Graduate School of Medicine, Tohoku University, 1-1 Seiryocho, Aoba-ku, Sendai, 980-8574, Japan. 2. Division of Cardiovascular Surgery, Graduate School of Medicine, Tohoku University, 1-1 Seiryocho, Aoba-ku, Sendai, 980-8574, Japan. shunsukekawamoto@med.tohoku.ac.jp. 3. Department of Diagnostic Pathology, Graduate School of Medicine, Tohoku University, Sendai, Japan. 4. Department of Medical Engineering and Cardiology, Tohoku University, Sendai, Japan.
Abstract
OBJECTIVES: Increased hemodynamic stress on vein grafts used in the arterial system is associated with vein graft disease. We determined whether a novel biodegradable external mesh stent could inhibit medial-intimal hyperplasia by suppressing hemodynamic stress on vein grafts and improve long-term patency. METHODS: Twenty-four beagles underwent bilateral femoral interposition grafting using reversed femoral veins. Vein grafts were externally supported by a novel poly L-lactide-ε-caprolactone copolymer (P(LA/CL)) biodegradable mesh stent or a nonabsorbable mesh stent. Vein grafts with no reinforcement were used as controls. The grafts were harvested 6 and 12 months after implantation for morphometric and immunohistochemical assessment. RESULTS: The endoluminal circumferential vein graft length was smaller in the P(LA/CL) and nonabsorbable groups (17.2 ± 2.9 and 19.0 ± 0.3 mm, respectively), than that in the control group (25.0 ± 2.6 mm, P < 0.01) at 12 months. The mean intimal-medial thickness was thinner in P(LA/CL) and nonabsorbable stent groups (0.18 ± 0.05 and 0.16 ± 0.05 mm, respectively), than that in the control group (0.30 ± 0.08 mm, P < 0.01). Differences in the intimal-medial thickness among the groups were associated with the magnitude of cellular proliferating activity. The graft patency ratio (100 %) was higher in the P(LA/CL) group than that in the nonabsorbable and control groups (72.2 and 63.6%, respectively, P < 0.05). CONCLUSIONS: The biodegradable P(LA/CL) external mesh stent improved vein graft patency for 12 months and prevented vein graft dilatation and intimal hyperplasia associated with suppressed neointimal layer cellular proliferating activity.
OBJECTIVES: Increased hemodynamic stress on vein grafts used in the arterial system is associated with vein graft disease. We determined whether a novel biodegradable external mesh stent could inhibit medial-intimal hyperplasia by suppressing hemodynamic stress on vein grafts and improve long-term patency. METHODS: Twenty-four beagles underwent bilateral femoral interposition grafting using reversed femoral veins. Vein grafts were externally supported by a novel poly L-lactide-ε-caprolactone copolymer (P(LA/CL)) biodegradable mesh stent or a nonabsorbable mesh stent. Vein grafts with no reinforcement were used as controls. The grafts were harvested 6 and 12 months after implantation for morphometric and immunohistochemical assessment. RESULTS: The endoluminal circumferential vein graft length was smaller in the P(LA/CL) and nonabsorbable groups (17.2 ± 2.9 and 19.0 ± 0.3 mm, respectively), than that in the control group (25.0 ± 2.6 mm, P < 0.01) at 12 months. The mean intimal-medial thickness was thinner in P(LA/CL) and nonabsorbable stent groups (0.18 ± 0.05 and 0.16 ± 0.05 mm, respectively), than that in the control group (0.30 ± 0.08 mm, P < 0.01). Differences in the intimal-medial thickness among the groups were associated with the magnitude of cellular proliferating activity. The graft patency ratio (100 %) was higher in the P(LA/CL) group than that in the nonabsorbable and control groups (72.2 and 63.6%, respectively, P < 0.05). CONCLUSIONS: The biodegradable P(LA/CL) external mesh stent improved vein graft patency for 12 months and prevented vein graft dilatation and intimal hyperplasia associated with suppressed neointimal layer cellular proliferating activity.
Authors: Jamie Y Jeremy; Richard Bulbulia; Jason L Johnson; Patricia Gadsdon; Vikram Vijayan; Nilima Shukla; Frank C T Smith; Gianni D Angelini Journal: J Thorac Cardiovasc Surg Date: 2004-06 Impact factor: 5.209
Authors: D Mehta; S J George; J Y Jeremy; M B Izzat; K M Southgate; A J Bryan; A C Newby; G D Angelini Journal: Nat Med Date: 1998-02 Impact factor: 53.440
Authors: Vikram Vijayan; Nilima Shukla; Jason L Johnson; Patricia Gadsdon; Gianni D Angelini; Frank C T Smith; Roger Baird; Jamie Y Jeremy Journal: J Vasc Surg Date: 2004-11 Impact factor: 4.268
Authors: Pedro D Pedroso; Bradley L Hershey; William Holman; Ramakrishna Venugopalan; Andreas S Anayiotos Journal: Technol Health Care Date: 2003 Impact factor: 1.285